Press Releases Year All Years 2020 2019 2018 2017 2016 2015 2014 Category All Releases Financial Releases Recro Pharma Enters Into Common Stock Purchase Agreement With Aspire Capital Feb 03, 2015 1:00pm EST Recro Pharma to Present at the 17th Annual BIO CEO & Investor Conference Feb 02, 2015 9:22pm EST Recro Pharma Reports Third Quarter 2014 Financial Results Nov 10, 2014 12:00pm EST Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery Oct 29, 2014 8:05pm EDT Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference Sep 08, 2014 11:00am EDT Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN Sep 04, 2014 8:51pm EDT Recro Pharma Reports Second Quarter 2014 Financial Results Aug 12, 2014 11:00am EDT Recro Pharma Added to Russell Microcap(R) Index Jun 30, 2014 11:00am EDT Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery Jun 17, 2014 11:30am EDT Recro Pharma Reports First Quarter 2014 Financial Results May 12, 2014 11:30am EDT Prev 1... 7 8 9 10 11 12 13 14 15 16 Next
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery Oct 29, 2014 8:05pm EDT
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference Sep 08, 2014 11:00am EDT
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN Sep 04, 2014 8:51pm EDT
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery Jun 17, 2014 11:30am EDT
